Congress Asset Management Co. Sells 71,221 Shares of Encompass Health Corporation $EHC

Congress Asset Management Co. cut its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 11.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 548,170 shares of the company’s stock after selling 71,221 shares during the quarter. Congress Asset Management Co. owned approximately 0.54% of Encompass Health worth $58,183,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Thrivent Financial for Lutherans lifted its stake in shares of Encompass Health by 57.8% during the 3rd quarter. Thrivent Financial for Lutherans now owns 1,194,859 shares of the company’s stock valued at $151,544,000 after buying an additional 437,464 shares in the last quarter. Ethic Inc. purchased a new position in Encompass Health in the 3rd quarter valued at approximately $1,272,000. Jennison Associates LLC raised its holdings in Encompass Health by 12.8% during the 3rd quarter. Jennison Associates LLC now owns 894,511 shares of the company’s stock valued at $113,621,000 after acquiring an additional 101,274 shares during the period. Marshall Wace LLP bought a new stake in Encompass Health during the 2nd quarter valued at $34,719,000. Finally, Tudor Investment Corp ET AL lifted its position in shares of Encompass Health by 155.3% during the third quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company’s stock worth $26,765,000 after acquiring an additional 128,191 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the subject of several recent research reports. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Barclays raised their target price on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a research note on Friday, February 6th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $143.29.

Insider Transactions at Encompass Health

In other Encompass Health news, Treasurer Edmund Fay sold 11,937 shares of the firm’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the sale, the treasurer owned 89,325 shares of the company’s stock, valued at $9,557,775. This trade represents a 11.79% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Mark J. Tarr sold 150,000 shares of Encompass Health stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total value of $16,746,000.00. Following the sale, the chief executive officer owned 377,070 shares of the company’s stock, valued at approximately $42,096,094.80. This trade represents a 28.46% decrease in their position. The SEC filing for this sale provides additional information. 2.00% of the stock is owned by corporate insiders.

Encompass Health Stock Performance

NYSE EHC opened at $97.54 on Tuesday. The company’s 50 day simple moving average is $102.81 and its two-hundred day simple moving average is $111.88. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.08 and a quick ratio of 1.08. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The stock has a market capitalization of $9.70 billion, a PE ratio of 17.61, a P/E/G ratio of 1.84 and a beta of 0.71.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. The firm had revenue of $3.09 billion during the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Wednesday, April 1st. Encompass Health’s dividend payout ratio is currently 13.72%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.